Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Technosphere Insulin inhalation safety in diabetic patients with asthma or COPD
2008-000564-16Phase 3Terminated
- Sponsor
- MannKind
- Start
- Apr 2013
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Technosphere insulin in diabetes mellitus type 1 (T1D) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by MannKind. Primary endpoint: Change in postbronchodilator FEV1 from screening to week 52. Started Apr 2013; status: terminated.
02
Drugs
Technosphere insulin
03
Conditions
diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-000564-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000564-16.